The Scientific Program - Headache

Print
Subject to change

Saturday, April 06, 2019

Hall B-PICASSO

07:00-08:00

E-Poster Presentations

08:00-09:40

SESSION 26 | HEADACHE: CONCEPT AND MECHANISMS

Chairpersons:

Krystyna Mitosek-Szewczyk, Poland & Gabriela Mih─âilescu, Romania

08:00-08:50

Migraine with aura and migraine without aura are the same disease.

Capsule: It is often debated whether migraine with aura and migraine without aura are etiologically distinct disorders. Do they share common pathophysiological pathways, such as cortical spreading  depression, blood flow changes, and genotype?

08:00-08:10

Host: Dimos Mitsikostas, Greece

08:10-08:25

Yes: Isabel Pavao Martins, Portugal

08:25-08:40

No: Margarita Sanchez-del-Rio, Spain

08:40-08:50

Discussion and rebuttals

08:50-9:40

Does the blood brain barrier (BBB) open during a migraine attack?

Capsule: Disruption of the BBB and inflammation are important contributors to the pathogenesis of neurological disorders. Although inflammation has been implicated in migraine pathogenesis, it is not known whether barrier integrity is compromised during attacks.

08:50-09:00

Host: Jose Miguel Lainez, Spain

09:00-09:15

Yes: Pablo Irimia Sieria, Spain

09:15-09:30

No: Messoud Ashina, Denmark

09:30-09:40

Discussion and rebuttals

09:40-11:45

SESSION 27 | NON-PHARMACOLOGICAL TREATMENT FOR HEADACHE

Chairpersons:

Maria Magdalena Wysocka-Bakowsa, Poland & Elsa Parreira, Portugal

09:40-10:30

Electrical stimulation will replace medications for the treatment of cluster headache.

Capsule: Neurostimulation is a rapidly growing field in headache disorders and provides an alternative therapeutic option particularly for cluster headache.

09:40-09:50

Host: Jack Schim, USA

09:50-10:05

Yes: Licia Grazzi, Italy

10:05-10:20

No: Giorgio Lambru, UK

10:20-10:30

Discussion and rebuttals

10:30-10:45

Coffee Break

10:45-12:25

SESSION 28 |

Chairpersons:

Ruta Mameniskiene, Lithuania & Elliot Gross, USA

10:45-11:15

Update on monoclonal antibody therapies and CGRP receptor antagonists in primary headache- Messoud Ashina, Denmark

11:15-11:45

Pipeline in headache treatment- Alan Rapoport, USA

11:45-12:25

FREE COMMUNICATIONS HEADACHE

12:25-13:25

Lunch Break

13:25-15:05

SESSION 29 | HEADACHE THERAPY

Chairpersons:

Angel Guerrero, Spain & George Chakhava, Georgia

13:25-15:05

Cognitive-behavioral therapy and biofeedback training are as effective as preventive medication in some patients.

Capsule: Medication and psychological intervention are often used in primary headache disorders. Can cognitive-behavioral therapy and biofeedback training replace preventive medication including CGRP blockers?

13:25-13:35

Host: Robert Shapiro, USA

13:35-13:50

Yes: Steve Baskin, USA

13:50-14:05

No: Mark Braschinsky, Estonia

14:05-14:15

Discussion and rebuttals

14:15-15:05

Monoclonal antibodies to CGRP will become first line treatment not only for migraine but also for episodic cluster headache.

Capsule: CGRP plays a crucial role in migraine pathophysiology. Monoclonal antibodies to CGRP or its receptor are promising new therapies for the treatment of other types of headache as well.

14:15-14:25

Host: Christian Lampl, Austria

14:25-14:40

Yes: Lars Edvinsson,  Sweden

14:40-14:55

No: Jose Miguel Lainez. Spain

14:55-15:05

Discussion and rebuttals

15:05-15:20

Coffee Break

15:20-17:50

SESSION 30 | HEADACHE DIAGNOSIS

Chairpersons:

Parisa Gazerani, Denmark & Ermal Kurmaku, Albania, Theodoros Constantinidis, Greece

15:20-16:10

 Computers can diagnose cluster headache better than the average doctor

Capsule: Personalized medicine (patient and doctor in the same room) is rapidly being replaced by modern e-techniques and information technology tools

15:20-15:30

Host: Min Kyung Chu, South Korea

15:30-15:45

Yes: Robert Cowan, USA

15:45-16:00

No: Giorgio Lambru, UK

16:00-16:10

Discussion and rebuttals

16:10-17:00

Thunderclap headache: Do we need more than head CT and lumbar puncture?

Capsule: Thunderclap headache is often but not exclusively caused by subarachnoid hemorrhage. CT and lumbar puncture are indicated when patients present with thunderclap headache, but do we need more than that?

16:10-16:20

Host: Robert Cowan, USA

16:20-16:35

Yes: Christian Lampl, Austria

16:35-16:50

No: Julio Pascual, Spain

16:50-17:00

Discussion and rebuttals

17:00-19:00

SESSION 31 |

17:00-17:50

Medical cannabis is effective in chronic headache

Capsule: The use of medical cannabis in patients with chronic headache varies widely, with contradicting data regarding its efficacy in chronic cluster headache, chronic migraine and chronic tension type headache.

17:00-17:10

Host: Manjit Matharu, UK

17:10-17:25

Yes: Brian McGeeney, USA

17:25-17:40

No: Dimos Mitsikostas, Greece

17:40-17:50

Discussion and rebuttals

17:50-18:05

New Players Headache

18:05-19:00

Headache Free Communications

END OF SATURDAY HALL B- PICASSO